Stock Analysis of Eli Lilly and Company (LLY) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code LLY
Close 770.00
Change -1.12 / 0.145 %
Volume 1669.05 K
Vol Change -630248.00 / 27.41 %
IndustryDrug Manufacturers-General
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index No Significant Profitability
Stability Index Low Stability Stock


Fundamental View of Eli Lilly and Company


Highs/Lows of Eli Lilly and Company
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week760.0 1.32 % 1.54 % 787.66750.5315-May-2413-May-24
Two Week734.97 4.77 % 3.42 % 787.66736.015-May-2406-May-24
One Month750.77 2.56 % 5.60 % 795.497718.330-Apr-2425-Apr-24
Three Month782.06 1.54 % 5.95 % 800.78718.304-Mar-2425-Apr-24
Six Months591.71 30.13 % 17.48 % 800.78562.00104-Mar-2415-Dec-23
One year437.47 76.01 % 27.52 % 800.78419.804-Mar-2425-May-23
Two year301.4 155.47 % 29.70 % 800.78302.1404-Mar-2424-Jan-23
Five year116.01 563.74 % 85.46 % 800.78101.3604-Mar-2423-Oct-19
Ten year58.34 1219.85 % 182.41 % 800.7858.2204-Mar-2419-May-14


Technical View of Eli Lilly and Company






Charts of Eli Lilly and Company


Returns of Eli Lilly and Company with Peers
Period / StockLLYJNJMRKABBVAZNNVO
1 Week1.32%3.16%0.869%3.53%-0.363%2.70%
1 Mth2.56%6.82%4.64%1.32%12.21%5.91%
3 Mth-1.54%-1.22%2.66%-6.24%19.65%6.35%
6mth30.13%3.24%28.93%20.33%19.91%30.08%
1 Year76.01%-2.74%14.32%16.09%2.95%57.86%
2 Year155.47%-13.52%41.06%7.52%17.15%148.05%
5 Years563.74%11.56%74.65%109.44%103.55%463.75%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Eli Lilly and Company with Peers
Ratio / StockLLYJNJMRKABBVAZNNVO
PE111.129.56-90.4249.1433.146.63
P/B59.305.438.2425.965.616.31
ROA10.4522.71-3.654.336.4230.91
ROE53.7956.98-8.9550.8516.9395.22
Debt To Equity2.340.4260.8565.730.7090.211
Revenue32072.50 M
12.37 %
85152.00 M
10.31 %
59315.00 M
0.054 %
54318.00 M
6.44 %
45811.00 M
3.29 %
232261 M
31.26 %
Net Income4988.40 M
20.12 %
14169.00 M
21.02 %
4608.00 M
68.26 %
4863.00 M
58.91 %
5955.00 M
81.11 %
83683.00 M
50.71 %


Technicals of Eli Lilly and Company with Peers
Technical / StockLLYJNJMRKABBVAZNNVO-
ADX16.9820.3218.5928.3853.6917.26
CMF0.00400.1430.02260.1120.03950.066
MFI50.1080.8033.4963.7243.8968.41
RSI53.0363.6859.7654.3070.9058.61
MACD Abv SignalTrueTrueTrueTrueFalseTrue
Price Above 50 MATrueTrueTrueFalseTrueTrue-
Price Above 200 MATrueFalseTrueTrueTrueTrue-


About : Eli Lilly and Company


Address : Lilly Corporate Center, Indianapolis, IN, United States, 46285
Tel : 317 276 2000
URL : https://www.lilly.com
Code : LLY, ISIN : US5324571083, Exchange : NYSE, Country : USA
Fiscal Year End : December
IPO date : 13_Jan_1978
Employee Count : 43000

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Note : All Data Generated at the End of Trading Hours (EOD Data)